This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmaceutical companies often struggle to actively involve patients in the design phase of clinicaltrials but doing so can have huge benefits for the sustainability and success of research. Improving the design of commercial research by listening to the patient voice.
in an effort to raise money and awareness promoting diversity on all levels in clinicaltrials. But obstacles loom for the plucky bikers, says Sergio Armani, ACRP Ride4DEI Creator, and EVP, BusinessDevelopment, Helios ClinicalResearch. This year it's scheduled to end May 20 in Washington D.C.
Clinicaltrials require precision and faultless execution for hypotheses to become therapies. For most of pharmaceutical history, this has made the potential benefits from outsourcing elements of these trials elusive. The world of clinicaltrials is changing.
The war in Ukraine has had a significant impact on clinicaltrials in Europe, exacerbating supply chain delays that were already causing multiple problems even before the Covid-19 pandemic intensified the situation. The company operates globally but was founded in Ukraine. We couldn’t put people’s lives at risk.
Just ask Michaele Linden-Johnson, FACHE, MBA, LCSW, director of clinicaltrials and businessdevelopment at the Medical Center of the Americas (MCA) Foundation Cardwell Collaborative in El Paso, Texas. We’re all about developing a workforce designed to reflect our patient population,” Linden-Johnson says.
Clinicaltrials require precision and faultless execution for hypotheses to become therapies. For most of pharmaceutical history, this has made the potential benefits from outsourcing elements of these trials elusive. The world of clinicaltrials is changing.
Pharma companies face many challenges when involving patients in the design of clinicaltrials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions. Linking pharma with patients.
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinicaltrials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinicaltrial design that have historically led to trial failure?
Clinicaltrials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. While many pieces of the drug development process have digitised to keep pace with the speed of technological advancements, clinicaltrials continue to lag amidst pharma’s digital transformation.
In doing so, the different types of virtual trials can also be better placed to produce valuable real-world evidence for their pharma industry sponsors, but they are not without their challenges and may not be suitable for every clinicaltrial. Increasing patient access to clinicaltrials.
COVID-19 has changed the way clinicalresearch sites look for studies. In addition, job seekers are also scrambling to find strategies for further developing their career pathways.
After experiencing significant growth in the clinicaltrial solutions market in 2021, Crucial Data Solutions has added another industry veteran to its leadership team. Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative low-code/no-code data and clinicaltrial management technology on the market today.
Dr. Amy Chan, senior clinicalresearch fellow at the School of Pharmacy, University of Auckland, says digital inhalers have existed for almost 30 years. There is also huge potential to use these data to inform future drug development and clinicaltrials of new asthma medication,” adds Chan.
Recognizing the need to support VirTrial’s customers around the globe, Emil Hoeck has been named International Director of BusinessDevelopment and will be based in Denmark. VirTrial is a telemedicine company providing a stable, long-standing virtual care management (VCM) platform to transform the clinicaltrial industry.
Professionally, especially in the world of clinicalresearch, the opposite is happening. We no longer have any option than to embrace technology and other unconditional approaches to decentralize clinicalresearch away from the study site. Dan McDonald, vice president, global businessdevelopment.
Velocity ClinicalResearch (“Velocity”), the largest integrated research site organisation globally, today announces it has strengthened its European senior executive team with three strategic hires, as the firm continues its expansion in the region. She completes the European executive team alongside Évelyne and Dominic.
Staffing and retention have been the top concern at research sites since 2020, with patient recruitment and enrollment ranking second, and the complexity of clinicaltrials ranking third, based on WCG survey data for 2020 to 2023. based clinicalresearch sites.
Some of the other educational sessions from the Saturday morning lineup of topics concentrated on the intricacies of pitching the availability of clinicaltrials to potential participants, and on incorporating the principles of best patient engagement practices into the training of clinicalresearch professionals.
The clinicaltrials landscape is evolving more rapidly than ever before. Meanwhile, decentralisation and the Big Data revolution are transforming the way researchers run clinicaltrials, and previously untapped geographies are emerging as new hubs for future research.
Velocity’s ongoing goals are to share best practices, identify and address shortcomings, and bring as many perspectives and viewpoints to the table as possible to advance clinicaltrials and deliver vital new drugs and treatments to patients quicker. Show the benefits of clinicaltrials. Think globally, act locally.
Velocity ClinicalResearch, the leading multi-specialty clinical sites business, today announces the appointment of Rachael Buck Ph.D. We’re doing things differently at Velocity, changing the way the industry thinks about clinicalresearch and streamlining the approach so that trials get done quicker.
We in the clinicaltrials industry are a community made up of countless numbers of people from thousands of companies. Below is our press release with details about the award: Dan McDonald of Imperial ClinicalResearch Services has been honored with the 10th Annual OECT Speaker Achievement Award.
In this case, it’s one of the founding members of a clinicaltrials site in Berlin, Germany, which has become the latest member of Velocity’s integrated site network in Europe. All founders have experience working in hospitals, which is where they first came across clinicalresearch.
That was the message from ‘The New Normal: Balancing the rapid evolution of trial design with patient need’ panel at the NIHR’s ClinicalResearch Network Virtual Event on Delivering Complex and Innovative Design (CID) Studies. Listening to patients. We also need to remember that patients still like going to doctors.
Collaboration provides clinicaltrial sponsors with access to the world’s most efficient clinical supply processes using a single contract. Together, we solve drug supply difficulties and navigate the many complexities — reducing supply chain risks and managing waste and costs throughout the stages of your clinicaltrial.
Client-Pharma proudly announces the appointment of Khaled El-Gendy as Vice President, Global BusinessDevelopment. Khaled, whom is based in Switzerland, brings with him more than twenty years of clinicaltrial supply chain excellence and experience. Client-Pharma is a specialist global clinicaltrial supply company.
Verily said the cash injection, led by Alphabet, will be used to support various development data-driven projects as well as funding possible “strategic partnerships, global businessdevelopment and…acquisitions.” — Amy Abernethy (@dramyabernethy) September 9, 2022.
Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of oligonucleotides with case studies surrounding the discovery and development of oligonucleotide therapeutics as well as CMC and regulatory standpoints.
The life sciences unit of Google parent Alphabet – which raised $1 billion back in September to fund its precision health agenda and businessdevelopment activities, including possible acquisitions – said the move would allow it to streamline its operations.
Cloudbyz, a fast-growing integrated ClinicalResearch and development solution provider in Healthcare & Life Science, has recently executed a CSR drive at the Samarthanam Trust for the Disabled showcasing its commitment to social responsibility by giving back to the community.
Prior to joining Calliditas Therapeutics as CMO, he held roles at GlaxoSmithKline (GSK) and Takeda, focusing on clinical and businessdevelopment in rare diseases. I’ve had a great passion for drug development in rare diseases,” says Dr. Philipson, underscoring a commitment that would shape his career’s trajectory.
Clinicaltrials technology company Saama has hired Dr Clinton White as its new chief delivery officer. Drawing on 25 years in clinicalresearch, White will oversee Saama’s project delivery teams. Pharmaceutical supplier PBSC has tapped Jose Ruiz as the new president and general manager for its US office.
Enrolling study subjects, setting up patient randomization and managing drug supply are critical to the success of a clinicaltrial. During her medical practice, Seredina worked in clinicalresearch as an investigator. She began her career at S-Clinical as a businessdeveloper and progressed to be the Head of Operations.
VectivBio AG – Based in Switzerland, VectivBio named Sarah Holland as chief business officer and Aditya Venugopal as head of businessdevelopment. O’Day has been a principal investigator for more than 200 clinicaltrials. Most recently, Holland served as Global Head of licensing at Lonza AG.
Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading businessdevelopment in industry. They felt there could be no one better than Dr. Lin to do businessdevelopment and look for compounds that fit their drug delivery technology.
Given enough time and exposure to multiple other areas of specialization in the clinicaltrials environment, many professionals who wish to continue working in the research arena, but who also desire a change of pace with new responsibilities, turn to project management. Ince: I have been in the industry for 20 years. I
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content